-
Je něco špatně v tomto záznamu ?
C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein Interaction
J. Klimek, O. Kruc, J. Ceklarz, B. Kamińska, B. Musielak, R. van der Straat, A. Dӧmling, TA. Holak, D. Muszak, J. Kalinowska-Tłuścik, Ł. Skalniak, E. Surmiak
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
UMO-2020/37/N/ST4/02691
National Science Center
POIR.04.04.00-00-420F/17-00
Foundation for Polish Science
POIR.04.02.00-00-D001/20
European Union in the framework of the Smart Growth Operational Program, Measure 4.2
Priority Research Area SciMat
Strategic Programme Excellence Initiative at Jagiellonian University
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antigeny CD274 * antagonisté a inhibitory metabolismus chemie MeSH
- antigeny CD279 * antagonisté a inhibitory metabolismus chemie MeSH
- inhibitory kontrolních bodů chemie farmakologie MeSH
- knihovny malých molekul farmakologie chemie MeSH
- lidé MeSH
- molekulární struktura MeSH
- simulace molekulového dockingu * MeSH
- terfenylové sloučeniny * chemie farmakologie MeSH
- vazba proteinů * MeSH
- vazebná místa MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The PD-1/PD-L1 complex is an immune checkpoint responsible for regulating the natural immune response, but also allows tumors to escape immune surveillance. Inhibition of the PD-1/PD-L1 axis positively contributes to the efficacy of cancer treatment. The only available therapeutics targeting PD-1/PD-L1 are monoclonal antibody-based drugs, which have several limitations. Therefore, small molecule compounds are emerging as an attractive alternative that can potentially overcome the drawbacks of mAb-based therapy. In this article, we present a novel class of small molecule compounds based on the terphenyl scaffold that bind to PD-L1. The general architecture of the presented structures is characterized by axial symmetry and consists of three elements: an m-terphenyl core, an additional aromatic ring, and a solubilizing agent. Using molecular docking, we designed a series of final compounds, which were subsequently synthesized and tested in HTRF assay and NMR binding assay to evaluate their activity. In addition, we performed an in-depth analysis of the mutual arrangement of the phenyl rings of the terphenyl core within the binding pocket of PD-L1 and found several correlations between the plane angle values and the affinity of the compounds towards the protein.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013569
- 003
- CZ-PrNML
- 005
- 20240905134145.0
- 007
- ta
- 008
- 240725s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules29112646 $2 doi
- 035 __
- $a (PubMed)38893521
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Klimek, Joanna $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $u Doctoral School of Exact and Natural Sciences, Jagiellonian University, Prof. St. Łojasiewicza St. 11, 30-348 Cracow, Poland $1 https://orcid.org/0000000159074141
- 245 10
- $a C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein-Protein Interaction / $c J. Klimek, O. Kruc, J. Ceklarz, B. Kamińska, B. Musielak, R. van der Straat, A. Dӧmling, TA. Holak, D. Muszak, J. Kalinowska-Tłuścik, Ł. Skalniak, E. Surmiak
- 520 9_
- $a The PD-1/PD-L1 complex is an immune checkpoint responsible for regulating the natural immune response, but also allows tumors to escape immune surveillance. Inhibition of the PD-1/PD-L1 axis positively contributes to the efficacy of cancer treatment. The only available therapeutics targeting PD-1/PD-L1 are monoclonal antibody-based drugs, which have several limitations. Therefore, small molecule compounds are emerging as an attractive alternative that can potentially overcome the drawbacks of mAb-based therapy. In this article, we present a novel class of small molecule compounds based on the terphenyl scaffold that bind to PD-L1. The general architecture of the presented structures is characterized by axial symmetry and consists of three elements: an m-terphenyl core, an additional aromatic ring, and a solubilizing agent. Using molecular docking, we designed a series of final compounds, which were subsequently synthesized and tested in HTRF assay and NMR binding assay to evaluate their activity. In addition, we performed an in-depth analysis of the mutual arrangement of the phenyl rings of the terphenyl core within the binding pocket of PD-L1 and found several correlations between the plane angle values and the affinity of the compounds towards the protein.
- 650 12
- $a antigeny CD274 $x antagonisté a inhibitory $x metabolismus $x chemie $7 D060890
- 650 12
- $a antigeny CD279 $x antagonisté a inhibitory $x metabolismus $x chemie $7 D061026
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a simulace molekulového dockingu $7 D062105
- 650 12
- $a vazba proteinů $7 D011485
- 650 12
- $a terfenylové sloučeniny $x chemie $x farmakologie $7 D013730
- 650 _2
- $a knihovny malých molekul $x farmakologie $x chemie $7 D054852
- 650 _2
- $a inhibitory kontrolních bodů $x chemie $x farmakologie $7 D000082082
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a vazebná místa $7 D001665
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kruc, Oskar $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $u Doctoral School of Exact and Natural Sciences, Jagiellonian University, Prof. St. Łojasiewicza St. 11, 30-348 Cracow, Poland $1 https://orcid.org/0000000344028817
- 700 1_
- $a Ceklarz, Joanna $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland
- 700 1_
- $a Kamińska, Beata $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $u Doctoral School of Exact and Natural Sciences, Jagiellonian University, Prof. St. Łojasiewicza St. 11, 30-348 Cracow, Poland $1 https://orcid.org/0009000792427026
- 700 1_
- $a Musielak, Bogdan $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $1 https://orcid.org/0000000216655920
- 700 1_
- $a van der Straat, Robin $u Department of Drug Design, University of Groningen, 9713 AV Groningen, The Netherlands $1 https://orcid.org/0000000250694042
- 700 1_
- $a Dӧmling, Alexander $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and Czech Advanced Technology and Research Institute, Palackӯ University in Olomouc, Křížkovského 511/8, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000299238873
- 700 1_
- $a Holak, Tad A $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $1 https://orcid.org/0000000193696024
- 700 1_
- $a Muszak, Damian $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $1 https://orcid.org/000000024876382X
- 700 1_
- $a Kalinowska-Tłuścik, Justyna $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $1 https://orcid.org/0000000177141651
- 700 1_
- $a Skalniak, Łukasz $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $1 https://orcid.org/0000000267076697
- 700 1_
- $a Surmiak, Ewa $u Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland $1 https://orcid.org/0000000241034675
- 773 0_
- $w MED00180394 $t Molecules $x 1420-3049 $g Roč. 29, č. 11 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38893521 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134139 $b ABA008
- 999 __
- $a ok $b bmc $g 2143398 $s 1225435
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 29 $c 11 $e 20240604 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a UMO-2020/37/N/ST4/02691 $p National Science Center
- GRA __
- $a POIR.04.04.00-00-420F/17-00 $p Foundation for Polish Science
- GRA __
- $a POIR.04.02.00-00-D001/20 $p European Union in the framework of the Smart Growth Operational Program, Measure 4.2
- GRA __
- $a Priority Research Area SciMat $p Strategic Programme Excellence Initiative at Jagiellonian University
- LZP __
- $a Pubmed-20240725